Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Karyopharm Therapeutics Inc a commercialstage pharmaceutical company pioneering novel cancer therapies today announced that it has entered into a clinical trial collaboration and supply agreement with BristolMyers Squibb
SELLAS Life Sciences Group Inc a latestage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications today announced that the US Food and Drug Administration
Novartis today announced positive topline results from the interim analysis of the ongoing pivotal Phase III ALIGN study of atrasentan an oral endothelin A receptor antagonist in patients with IgA nephropathy
Santhera Pharmaceuticals announces that the US Food and Drug Administration has approved AGAMREE oral suspension mgml for the treatment of Duchenne muscular dystrophy in patients years of age and older
Mustang Bio Inc a clinicalstage biopharmaceutical company focused on translating todays medical breakthroughs in cell and gene therapies into potential cures for difficulttotreat cancers and rare genetic diseases
CanFite BioPharma Ltd a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncology and inflammatory diseases today announced that it entered into an agreement
Schreiner MediPharm has developed a reliable blinding solution for vials used for clinical dosing The selfadhesive film labels are colored as well as semitransparent As a result the different liquids of the investigational drug
Biogen Inc reported new Phase b clinical data from the study of BIIB an investigational antisense oligonucleotide therapy targeting tau in mild Alzheimers disease The data showed favorable trends on multiple exploratory endpoints of cognition
Araclon Biotech a Grifols Group company dedicated to the research and development of therapies and diagnostic methods applied to neurodegenerative diseases today announced encouraging final results from its Phase trial
Immatics NV NASDAQ IMTX Immatics a clinicalstage biopharmaceutical company active in the discovery and development of T cellredirecting cancer immunotherapies today announced that its IMA TCRT program
